Written on
October 1, 2022

Penicillins and Vancomycin in the Kidney - from CAMERA2 to SNAP

Presentation by Amy Legg, clinical pharmacist in infectious diseases at Royal Brisbane & Women's Hospital and Menzies School of Health Research
Homeicon-breadcrumbNewsSnap in the Mediaicon-breadcrumb
Penicillins and Vancomycin / By Amy Legg

Amy Legg is an experienced clinical pharmacist in infectious diseases and antimicrobial stewardship. Her research interests include effects of penicillin allergy on patient outcomes and process for allergy assessment, therapeutic drug monitoring to ensure efficacy and safety, and uptake and efficacy of the hepatitis C medications.

More Trial Updates & Blog Posts

More News
Written on
July 25, 2022

Staphylococcus aureus Network Adaptive Platform – Paediatric and Youth (SNAP-PY)

The SNAP trial includes all age groups because people of all ages.

icon-benefit
SNAP Trial Resource
Written on
November 12, 2021

Staphylococcus aureus and Penicillin: Intertwined throughout history

A summary of how Staphylococcus aureus and penicillin have been instrumental in both the success and failure of one another since they met. Carly Botheras (PhD Candidate, Geelong Centre for Emerging Infectious Diseases, Barwon Health)

icon-benefit
SNAP Trial Resource
Written on
October 29, 2021

Urinary biomarkers

Amy Legg (Clinical Pharmacist) and Prof Marc Scheetz (Professor of Pharmacy and Pharmacology at Midwestern University) explain one of the proposed SNAP substudies involving novel urinary biomarkers.

icon-benefit
SNAP Trial Resource
BACK TO TOP